US › Healthcare

Icecure Medical (ICCM)

US · Healthcare · Medical Devices

$3.13+12.59%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$911,000
Revenue YoY
+25.7%
Net profit
$-4.3M
Profit YoY
-19.1%
EPS
$-0.06
EPS estimate
$-0.05
Net margin
-469.2%

EPS came in at -0.06 against a street estimate of -0.05 — a miss of 16.2%.

Key statistics

Market cap
$9.9M
Forward P/E
0.0
P/B
1.17
Book value
$3.14
EPS (TTM)
$-7.20
52-week high
$42.00
52-week low
$2.12
50-day MA
$4.54
200-day MA
$14.10
Beta
1.54

Analyst view

Analysts rate Icecure Medical a buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $30.50.

Shareholding

Insiders
32.72%
Institutions
3.66%

Largest institutional holders

FundStake
Armistice Capital, LLC2.64%
Gunderson Capital Management Inc0.58%
UBS Group AG0.15%
Warberg Asset Management LLC0.06%
HRT FINANCIAL LLC0.05%
Geode Capital Management, LLC0.04%
Hudson Bay Capital Management LP0.03%
Morgan Stanley - Brokerage Accounts0.02%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Icecure Medical — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.